Apollomics, Inc.
APLMNASDAQHealthcare● Active
$13.96
$-0.04(-0.29%)
Market Cap$15402738
P/E Ratio—
52W High$42.12
52W Low$3.659
Apollomics, Inc. (APLM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
APLM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 27, 2026EPS Actual
$3.80
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 27, 2026
After Market Close
APLM reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 24, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Sep 24, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | Apr 27, 2026 | — | $3.80 | — | — | — | — |
| — Q2 FY2025 | Jun 30, 2025 | — | -$11.37 | — | $0.01B | — | — |
| ◌ Q2 FY2025 | Apr 3, 2025 | — | — | — | — | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$16.92 | — | $-0.00B | — | — |
| ▼ Q1 FY2024 | Mar 28, 2024 | -$0.16 | -$24.00 | -14900.0% | — | — | — |
| ▼ Q1 FY2024 | Mar 28, 2024 | -$0.16 | -$24.39 | -15143.3% | $0.00B | — | — |
Q3 FY2026
Sep 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 27, 2026
EPS Actual
$3.80
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 30, 2025
EPS Actual
-$11.37
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
Apr 3, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 31, 2024
EPS Actual
-$16.92
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.00B
Q1 FY2024
Mar 28, 2024Miss
EPS Actual
-$24.00
EPS Est.
-$0.16
EPS Surpr.
-14900.0%
Revenue
—
Q1 FY2024
Mar 28, 2024Miss
EPS Actual
-$24.39
EPS Est.
-$0.16
EPS Surpr.
-15143.3%
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 27, 2026 | — | $13.28 | $13.19 | -0.68% |
| — Q2 FY2025 | Jun 30, 2025 | — | $6.51 | $6.56 | +0.77% |
| — Q4 FY2024 | Dec 31, 2024 | — | $10.13 | $9.75 | -3.75% |
| ▼ Q1 FY2024 | Mar 28, 2024 | -14900.0% | $60.50 | $75.00 | +23.97% |
| ▼ Q1 FY2024 | Mar 28, 2024 | -15143.3% | $60.50 | $75.00 | +23.97% |
| ▼ Q3 FY2023 | Sep 28, 2023 | -159275.0% | $388.00 | $394.00 | +1.55% |
| ▼ Q3 FY2023 | Sep 28, 2023 | -159533.5% | $388.00 | $394.00 | +1.55% |
| — Q2 FY2023 | Apr 28, 2023 | — | $476.00 | $464.00 | -2.52% |
Q2 FY2026-0.68%
Report Date
Apr 27, 2026
EPS Beat/Miss
—
Price Before
$13.28
Price After
$13.19
Q2 FY2025+0.77%
Report Date
Jun 30, 2025
EPS Beat/Miss
—
Price Before
$6.51
Price After
$6.56
Q4 FY2024-3.75%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$10.13
Price After
$9.75
Q1 FY2024+23.97%
Report Date
Mar 28, 2024
EPS Beat/Miss
-14900.0%
Price Before
$60.50
Price After
$75.00
Q1 FY2024+23.97%
Report Date
Mar 28, 2024
EPS Beat/Miss
-15143.3%
Price Before
$60.50
Price After
$75.00
Q3 FY2023+1.55%
Report Date
Sep 28, 2023
EPS Beat/Miss
-159275.0%
Price Before
$388.00
Price After
$394.00
Q3 FY2023+1.55%
Report Date
Sep 28, 2023
EPS Beat/Miss
-159533.5%
Price Before
$388.00
Price After
$394.00
Q2 FY2023-2.52%
Report Date
Apr 28, 2023
EPS Beat/Miss
—
Price Before
$476.00
Price After
$464.00
Avg Miss Reaction+12.76%
Beat Rate0 / 8 quarters
Largest Move+23.97% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: APLM ends December
Apollomics, Inc. (APLM) most recently reported earnings on April 27, 2026 for Q2 FY2026, posting EPS of $3.80 (in line with the analyst consensus of —). The next APLM earnings date is expected around September 1, 2026.
Each quarter, investors track APLM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. APLM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
APLM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
APLM earnings · 4 questionsApollomics, Inc.'s next earnings report is expected around September 1, 2026. APLM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; APLM historically reports after market close (AMC).
APLM earnings datewhen is APLM earningsAPLM next earnings datewhen does APLM report earningsAPLM earnings calendar
▸ Source: FMP · Apollomics, Inc. SEC filings · US GAAP · Apollomics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026